Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02182921
Other study ID # NSFC/YOUNG-81100653
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 2013
Est. completion date December 2030

Study information

Verified date February 2023
Source Evidence Based Cataract Study Group
Contact Yi Lu, MD
Phone (86)021-64377134
Email luyieent@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the visual outcome of the cataract surgery, including best uncorrected and corrected visual acuity, spherical equivalent, wavefront aberration and other measurements.


Recruitment information / eligibility

Status Recruiting
Enrollment 20000
Est. completion date December 2030
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender All
Age group N/A to 90 Years
Eligibility Inclusion Criteria: - Clinical diagnosis of cataract - Must be able to cooperate with the ophthalmic examination Exclusion Criteria: - Clinical diagnosis of mental illness - Mentally disabled

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Eye and ENT Hospital of Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Evidence Based Cataract Study Group

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other The difference between attempted and achieved refractive correction at one month after cataract surgery Follow-up until one month after surgery
Other The difference between attempted and achieved refractive correction at six months after cataract surgery Follow-up until six months after surgery
Primary Change from baseline in visual acuity at one month after cataract surgery Follow-up until one month after surgery
Primary Change from baseline in spherical equivalent at one month after cataract surgery Follow-up until one month after surgery
Primary Change from baseline in visual acuity at six months after cataract surgery Follow-up until six months after surgery
Primary Change from baseline in spherical equivalent at six months after cataract surgery Follow-up until six months after cataract surgery
Secondary Change from baseline in wavefront aberration at one month after cataract surgery Follow-up until one month after surgery
Secondary Change from baseline in contrast sensitivity at one month after cataract surgery Follow-up until one month after surgery
Secondary Change from baseline in intraocular light scattering at one month after cataract surgery Follow-up until one month after surgery
Secondary Change from baseline in wavefront aberration at six months after cataract surgery Follow-up until six months after surgery
Secondary Change from baseline in contrast sensitivity at six months after cataract surgery Follow-up until six months after surgery
Secondary Change from baseline in intraocular light scattering at six months after cataract surgery Follow-up until six months after surgery
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A